Provided by Tiger Fintech (Singapore) Pte. Ltd.

Windtree Therapeutics, Inc.

0.4645
+0.01503.34%
Volume:312.72K
Turnover:141.18K
Market Cap:1.70M
PE:-0.01
High:0.4700
Open:0.4600
Low:0.4400
Close:0.4495
Loading ...

Windtree Therapeutics announces agreement to acquire Titan Environmental

TIPRANKS
·
10 Jun

Windtree Therapeutics Inc - to Buy Titan Environmental Services

THOMSON REUTERS
·
10 Jun

Windtree Announces Transformational Agreement to Acquire Revenue Generating Environmental Services Business

THOMSON REUTERS
·
10 Jun

Windtree Therapeutics Inc - to Issue Preferred Shares and Secure Debt Financing to Fund Deal

THOMSON REUTERS
·
10 Jun

Windtree Therapeutics Inc - Refocused Strategy Expected to Generate $12 Mln in Revenue

THOMSON REUTERS
·
10 Jun

Windtree Therapeutics announces plan for cryptocurrency treasury policy

TIPRANKS
·
04 Jun

BRIEF-Windtree Therapeutics Inc - To Create Cryptocurrency Policy For Payments And Assets

Reuters
·
04 Jun

Windtree Therapeutics Inc - to Create Cryptocurrency Policy for Payments and Assets

THOMSON REUTERS
·
04 Jun

Windtree Therapeutics Inc - in Discussions to Accept Bitcoin and Other Cryptocurrencies

THOMSON REUTERS
·
04 Jun

BRIEF-Windtree Therapeutics Announces Istaroxime Cardiogenic Shock SCAI Stage C Phase 2 Study Planned Interim Analysis Results Targeted for July 2025

Reuters
·
22 May

Windtree Therapeutics Announces Istaroxime Cardiogenic Shock Scai Stage C Phase 2 Study Planned Interim Analysis Results Targeted for July 2025

THOMSON REUTERS
·
22 May

Windtree Therapeutics files to sell 42.17M shares of common stock for holders

TIPRANKS
·
17 May

Windtree Therapeutics Q4 EPS $(4.63) Beats $(28.82) Estimate

Benzinga
·
16 May

BRIEF-Windtree Therapeutics Q1 Net Income USD -4.045 Million

Reuters
·
16 May

Windtree Therapeutics Reports First Quarter 2025 Financial Results and Provides Key Business Updates

THOMSON REUTERS
·
16 May

Windtree Therapeutics Q1 Operating Income USD -4.09 Million

THOMSON REUTERS
·
16 May

Windtree Therapeutics: Qtrly Net Loss $4.63 per Share

THOMSON REUTERS
·
16 May

Evofem Biosciences Reports Q1 2025 Net Income of $1M, Reversing $4.9M Loss YoY; EPS at $0.01

Reuters
·
15 May

Windtree Announces Strategic Transaction to Drive Revenue Generation in Support of Ongoing Therapeutic Pipeline Development

GlobeNewswire
·
01 May

Windtree Therapeutics FY 2024 GAAP EPS $(104.35)

Benzinga
·
15 Apr